Macrophages internalize and degrade proteins modified by advanced glycosylation end products (AGEs) via a specific receptor (AGE-R). Chemical cross-linking studies with AGE-bovine serum albumin have demonstrated that the molecular weight of this receptor is ∼90,000. We previously established that the binding constant (Ka) of this receptor site for the chemically synthesized model AGE, 2-(2-furoyl)-4(5)-(2-furanyl)-1H-imidazole-butyric acid (FFI-BA), on cells of the mouse macrophagelike cell line RAW 264.7 is identical to that for AGE proteins. Therefore, FFI was used as an affinity matrix in the first purification step of the AGE-R. The membranes of RAW 264.7 cells were solubilized in octyl-β-glucoside and subjected to affinity chromatography on FFI-sepharose and gel permeation on Superose 6 fast protein liquid chromatography. Sodium dodecyl sulfate (SDS)–polyacrylamide gel electrophoresis analysis of this material revealed a high enrichment of a 90,000-Mr protein that had AGE binding activity. Approximately 25% of the protein at this step was the 90,000-Mr protein. The 90,000-Mr membrane protein was purified to homogeneity by rechromatographing the material on Superose 12 in the presence of SDS before and after reduction with 2-mercaptoethanol. After these harsh conditions, the 90,000-Mr protein lost AGE binding activity. Additional cross-linking studies on human peripheral monocytes revealed an AGE-R protein of identical size to that on RAW 264.7 cells, suggesting the relatively highly conserved nature of this molecule. Given the large heterogeneity of the AGE structures, this AGE-R may represent one of a family of receptors present on a diverse group of different cell types having multiple functions. The implications of this macrophage receptor system in normal tissue remodeling and in proliferative/degenerative diseases are discussed.
Skip Nav Destination
Article navigation
Original Articles|
December 01 1990
Isolation of Surface Binding Protein Specific for Advanced Glycosylation End Products From Mouse Macrophage-Derived Cell Line RAW 264.7
Steven Radoff;
Steven Radoff
Laboratory of Medical Biochemistry, The Rockefeller University
New York, New York
Search for other works by this author on:
Anthony Cerami;
Anthony Cerami
Laboratory of Medical Biochemistry, The Rockefeller University
New York, New York
Search for other works by this author on:
Helen Vlassara
Helen Vlassara
Laboratory of Medical Biochemistry, The Rockefeller University
New York, New York
Search for other works by this author on:
Please address correspondence and reprint requests to Dr. Helen Vlassara, Laboratory of Medical Biochemistry, The Rockefeller University, 1230 York Avenue, New York, NY 10021.
Diabetes 1990;39(12):1510–1518
Article history
Received:
February 07 1990
Revision Received:
June 29 1990
Accepted:
June 29 1990
PubMed:
2174009
Citation
Steven Radoff, Anthony Cerami, Helen Vlassara; Isolation of Surface Binding Protein Specific for Advanced Glycosylation End Products From Mouse Macrophage-Derived Cell Line RAW 264.7. Diabetes 1 December 1990; 39 (12): 1510–1518. https://doi.org/10.2337/diab.39.12.1510
Download citation file:
49
Views